导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.85% | 1054/4773 |
| 近一周 | -1.38% | 2101/5465 |
| 近一月 | -6.21% | 4090/5421 |
| 近一季 | -14.16% | 4252/5231 |
| 近半年 | 4.87% | 841/4920 |
| 近一年 | 12.36% | 956/4394 |
| 近两年 | 102.66% | 613/2954 |
| 近三年 | 72.13% | 323/2253 |
| 成立以来 | 42.95% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.99% 3994/4961 |
49.01% 623/5312 |
- - |
- - |
| 2025 | 41.81% 722/4813 |
2.45% 1367/3635 |
-2.04% 3298/4076 |
42.59% 687/4524 |
-0.90% 2705/4813 |
| 2024 | 14.50% 1040/3463 |
-4.76% 1761/2808 |
2.96% 295/3014 |
12.96% 2268/3129 |
3.37% 834/3463 |
| 2023 | 4.79% 215/2656 |
16.57% 195/2280 |
0.76% 277/2385 |
-9.68% 1876/2515 |
-1.22% 301/2655 |
| 2022 | -33.45% 1703/2207 |
-23.93% 1751/1919 |
2.76% 1260/2016 |
-17.00% 1536/2113 |
2.57% 891/2208 |
| 2021 | - - |
- - |
22.10% 125/1330 |
-7.70% 1076/1466 |
11.11% 92/1822 |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.6144 | 32.25% |
| 景顺长城中证港股通创新药ETF | 1.6764 | 32.17% |
| 港股医疗 | 0.9539 | 31.90% |
| 港股医疗ETF | 1.4546 | 31.90% |
| 港股通医疗ETF工银 | 0.9639 | 31.81% |
| 港股通医疗ETF华宝 | 0.9752 | 31.64% |
| 万家中证港股通创新药ETF发起式联接A | 1.4069 | 31.06% |
| 万家中证港股通创新药ETF发起式联接C | 1.4061 | 30.98% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 嘉实中证港股通创新药指数发起式A | 0.8590 | 30.57% |
| 华泰柏瑞中证物联网主题ETF VS. 长安沪深300非周期A(740101) |